EGLN3 and familial pancreatic carcinoma: Recombinant overexpression of PHD3 inhibited pancreatic cancer growth in nude mice substantially (Figure 5A), as the average sizes of PHD3 overexpressing tumours was significantly smaller when compared with control xeonograft tumours (P<0.05).